| Literature DB >> 28709801 |
Lucas Onder1, Urs Mörbe1, Natalia Pikor1, Mario Novkovic1, Hung-Wei Cheng1, Thomas Hehlgans2, Klaus Pfeffer3, Burkhard Becher4, Ari Waisman5, Thomas Rülicke6, Jennifer Gommerman7, Christopher G Mueller8, Shinichiro Sawa9, Elke Scandella1, Burkhard Ludewig10.
Abstract
Lymph nodes (LNs) are strategically situated throughout the body at junctures of the blood vascular and lymphatic systems to direct immune responses against antigens draining from peripheral tissues. The current paradigm describes LN development as a programmed process that is governed through the interaction between mesenchymal lymphoid tissue organizer (LTo) cells and hematopoietic lymphoid tissue inducer (LTi) cells. Using cell-type-specific ablation of key molecules involved in lymphoid organogenesis, we found that initiation of LN development is dependent on LTi-cell-mediated activation of lymphatic endothelial cells (LECs) and that engagement of mesenchymal stromal cells is a succeeding event. LEC activation was mediated mainly by signaling through receptor activator of NF-κB (RANK) and the non-canonical NF-κB pathway and was steered by sphingosine-1-phosphate-receptor-dependent retention of LTi cells in the LN anlage. Finally, the finding that pharmacologically enforced interaction between LTi cells and LECs promotes ectopic LN formation underscores the central LTo function of LECs.Keywords: fibroblastic reticular cells; lymph node organogenesis; lymphatic and blood endothelial cells; lymphoid stromal cells; lymphoid tissue organizer cells; mesenchymal stromal cells
Mesh:
Substances:
Year: 2017 PMID: 28709801 DOI: 10.1016/j.immuni.2017.05.008
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745